Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Myricetin bioactive effects: Moving from preclinical evidence to potential clinical applications

  • Yasaman Taheri
  • , Hafiz Ansar Rasul Suleria
  • , Natália Martins
  • , Oksana Sytar
  • , Ahmet Beyatli
  • , Balakyz Yeskaliyeva
  • , Gulnaz Seitimova
  • , Bahare Salehi
  • , Prabhakar Semwal
  • , Sakshi Painuli
  • , Anuj Kumar
  • , Elena Azzini
  • , Miquel Martorell
  • , William N. Setzer
  • , Alfred Maroyi
  • , Javad Sharifi-Rad
  • Shahid Beheshti University of Medical Sciences
  • University of Melbourne
  • University of Porto
  • Kyiv National Taras Shevchenko University
  • Slovak University of Agriculture in Nitra
  • University of Health Sciences
  • Al Farabi Kazakh National University
  • Bam University of Medical Sciences
  • Graphic Era
  • Uttarakhand State Council for Science and Technology
  • Himalayan Environmental Studies and Conservation Organization
  • Uttarakhand Council for Biotechnology (UCB)
  • CREA-Research Centre for Food and Nutrition
  • Universidad de Concepción
  • University of Alabama in Huntsville
  • Aromatic Plant Research Center
  • University of Fort Hare
  • Zabol University of Medical Sciences

Producción científica: Contribución a una revistaArtículo de revisiónrevisión exhaustiva

216 Citas (Scopus)

Resumen

Several flavonoids have been recognized as nutraceuticals, and myricetin is a good example. Myricetin is commonly found in plants and their antimicrobial and antioxidant activities is well demonstrated. One of its beneficial biological effects is the neuroprotective activity, showing preclinical activities on Alzheimer, Parkinson, and Huntington diseases, and even in amyotrophic lateral sclerosis. Also, myricetin has revealed other biological activities, among them as antidiabetic, anticancer, immunomodulatory, cardiovascular, analgesic and antihypertensive. However, few clinical trials have been performed using myricetin as nutraceutical. Thus, this review provides new insights on myricetin preclinical pharmacological activities, and role in selected clinical trials.

Idioma originalInglés
Número de artículo241
PublicaciónBMC Complementary and Alternative Medicine
Volumen20
N.º1
DOI
EstadoPublicada - 1 ago. 2020
Publicado de forma externa

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

  1. ODS 3: Salud y bienestar
    ODS 3: Salud y bienestar

Huella

Profundice en los temas de investigación de 'Myricetin bioactive effects: Moving from preclinical evidence to potential clinical applications'. En conjunto forman una huella única.

Citar esto